Dennis W Dickson Selected Research

Parkinsonian Disorders (Parkinsonism)

2/2022	Diffuse Lewy body disease presenting as Parkinson's disease with progressive aphasia.
1/2022	Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
12/2021	Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review.
1/2021	MRI quantitative susceptibility mapping of the substantia nigra as an early biomarker for Lewy body disease.
12/2020	Association of mitochondrial genomic background with risk of Multiple System Atrophy.
1/2020	Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
1/2019	Association of MAPT H1 subhaplotypes with neuropathology of lewy body disease.
1/2018	Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy.
1/2018	Establishing diagnostic criteria for Perry syndrome.
1/2018	Diffuse Lewy body disease manifesting as corticobasal syndrome: A rare form of Lewy body disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dennis W Dickson Research Topics

Disease

111	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 10/2003
77	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 02/2022 - 05/2005
73	Frontotemporal Dementia (Semantic Dementia) 02/2022 - 10/2003
63	Dementia (Dementias) 01/2022 - 01/2002
51	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 11/2002
41	Parkinson Disease (Parkinson's Disease) 01/2021 - 01/2002
40	Tauopathies 01/2022 - 06/2002
39	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2022 - 02/2004
37	Parkinsonian Disorders (Parkinsonism) 02/2022 - 01/2002
37	Lewy Body Disease (Lewy Body Dementia) 01/2022 - 08/2008
34	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2022 - 10/2002
23	Cognitive Dysfunction 02/2022 - 01/2004
21	Atrophy 01/2022 - 04/2005
21	Synucleinopathies 12/2021 - 10/2004
21	Multiple System Atrophy 01/2021 - 01/2004
20	Corticobasal Degeneration 06/2022 - 10/2003
18	Amyloid Plaque 01/2019 - 10/2002
11	Hippocampal Sclerosis 01/2020 - 01/2004
10	Pick Disease of the Brain (Pick's Disease) 01/2021 - 11/2003
10	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2021 - 05/2005
9	Gliosis 11/2020 - 10/2002
8	Proteostasis Deficiencies 01/2022 - 07/2008
6	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 11/2021 - 05/2015
6	TDP-43 Proteinopathies 11/2020 - 07/2008
5	Disease Progression 01/2022 - 07/2008
5	Neuroinflammatory Diseases 09/2021 - 11/2006
5	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 07/2010
4	Ischemia 01/2008 - 09/2005
3	Hallucinations (Hallucination) 02/2022 - 08/2016
3	REM Sleep Behavior Disorder 02/2022 - 08/2016
3	COVID-19 01/2022 - 02/2021
3	Cerebellar Ataxia (Dysmetria) 01/2022 - 09/2008
3	Chronic Traumatic Encephalopathy 12/2021 - 01/2016
3	Ataxia (Dyssynergia) 12/2020 - 06/2004
3	Amyloidosis 11/2020 - 01/2014
3	Memory Disorders (Memory Loss) 01/2019 - 01/2014
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019 - 10/2008
3	Weight Loss (Weight Reduction) 01/2018 - 08/2017
3	Tremor (Tremors) 01/2016 - 09/2003
3	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2016 - 06/2008
3	Inflammation (Inflammations) 01/2015 - 01/2008
3	Neoplasms (Cancer) 08/2013 - 06/2004
3	Globoid Cell Leukodystrophy (Krabbe Disease) 08/2007 - 09/2005
2	Demyelinating Diseases (Demyelinating Disease) 05/2022 - 01/2020
2	Rupture 02/2021 - 01/2017
2	Disease Susceptibility (Diathesis) 01/2021 - 10/2013
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021 - 08/2011

Drug/Important Bio-Agent (IBA)

78	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
53	DNA-Binding Proteins (DNA Binding Protein)IBA 11/2022 - 05/2007
51	Amyloid (Amyloid Fibrils)IBA 01/2022 - 10/2003
37	SynucleinsIBA 01/2022 - 01/2007
36	UbiquitinIBA 01/2021 - 04/2003
33	ProgranulinsIBA 01/2021 - 11/2006
29	Apolipoproteins E (ApoE)IBA 11/2021 - 01/2003
23	alpha-SynucleinIBA 12/2020 - 08/2002
21	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2007
21	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021 - 04/2003
20	ApolipoproteinsIBA 01/2022 - 01/2002
15	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2003
14	Amyloid beta-PeptidesIBA 01/2021 - 10/2002
13	tau Proteins (tau Protein)IBA 11/2019 - 07/2004
13	Phosphotransferases (Kinase)IBA 01/2017 - 12/2005
12	Levodopa (L Dopa)FDA LinkGeneric 02/2022 - 01/2002
12	Protein Isoforms (Isoforms)IBA 01/2022 - 06/2002
12	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2003
11	Leucine (L-Leucine)FDA Link 01/2017 - 05/2007
8	Apolipoprotein E4IBA 01/2022 - 05/2005
7	DipeptidesIBA 01/2021 - 01/2017
7	Peptides (Polypeptides)IBA 11/2020 - 12/2005
6	7- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA 11/2020 - 01/2016
6	Presenilin-1IBA 01/2017 - 06/2007
5	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022 - 10/2012
5	Carrier Proteins (Binding Protein)IBA 01/2022 - 08/2012
5	Monoclonal AntibodiesIBA 11/2020 - 06/2002
5	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 11/2002
5	EnzymesIBA 12/2017 - 09/2005
5	Messenger RNA (mRNA)IBA 09/2013 - 01/2010
4	LipidsIBA 05/2022 - 04/2004
4	AntibodiesIBA 01/2020 - 06/2002
4	MicroRNAs (MicroRNA)IBA 01/2016 - 12/2008
3	Mitochondrial DNA (mtDNA)IBA 01/2022 - 01/2020
3	IronIBA 01/2022 - 06/2010
3	Amino Acids FDA Link 01/2022 - 11/2011
3	poly(glycyl-alanyl)IBA 01/2021 - 10/2015
3	NucleotidesIBA 01/2021 - 07/2015
3	PrionsIBA 11/2019 - 01/2016
3	Biological ProductsIBA 12/2018 - 11/2017
3	Protein AggregatesIBA 07/2017 - 10/2016
3	Protein Glutamine gamma Glutamyltransferase 2IBA 10/2016 - 01/2008
3	N 30IBA 01/2015 - 01/2009
3	Protons (Proton)IBA 12/2014 - 08/2012
3	Neprilysin (Neutral Endopeptidase)IBA 01/2013 - 10/2003
3	GalactosylceramidaseIBA 08/2007 - 09/2005
2	Cholinergic Agents (Cholinergics)IBA 01/2022 - 01/2018
2	IGF-I-IGFBP-3 complex FDA Link 01/2022 - 03/2014
2	CytokinesIBA 01/2022 - 11/2011
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 11/2021 - 08/2014
2	Apolipoprotein E3IBA 09/2021 - 01/2020
2	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2021 - 06/2014

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2006